Oral bioavailability of cantharidin-loaded solid lipid nanoparticles

BACKGROUND: The clinical application of cantharidin (CA) is limited by its insolubility, toxicity and short half-life in circulation. This study aims to achieve a steady and sustained blood concentration–time profile, using solid lipid nanoparticles (SLNs) as a drug carrier. METHODS: CA-SLNs were pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dang, Yun-Jie, Zhu, Chun-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615953/
https://www.ncbi.nlm.nih.gov/pubmed/23298453
http://dx.doi.org/10.1186/1749-8546-8-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615953/
https://www.ncbi.nlm.nih.gov/pubmed/23298453
http://dx.doi.org/10.1186/1749-8546-8-1

Ejemplares similares